A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivativesShopnil Akash, Rohit Sharma, İmren Bayıl et al.|PLoS ONE|2023Cited by 48